Caribou Biosciences stock price
카리부 바이오사이언시스NASDAQ:CRBU · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Caribou Biosciences last closed at $1.22 (+0.00%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -1.2×. Its overall grade ranks 587 of 739 stocks in Healthcare.
About this company
Caribou Biosciences last closed at $1.22 (+0.00%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 587/739
Valuation grade C+
Related stocks
- Editas MedicineCompetitor
CRISPR 유전자편집 치료제 개발 경쟁사
- Intellia TherapeuticsCompetitor
CRISPR 기반 유전자편집 치료제 핵심 경쟁사
- Beam TherapeuticsCompetitor
차세대 유전자편집/베이스에디팅 경쟁사
About Caribou Biosciences
- What technical signals does Caribou Biosciences (CRBU) have?
- Caribou Biosciences current technical signals: MACD bullish cross.
- Is Caribou Biosciences a cup-and-handle pattern?
- No. Caribou Biosciences has no valid Cup signal right now.
- What published figures are available for Caribou Biosciences?
- Market cap: $114.03M. Trailing 12 months PER: -1.2×. Latest quarter PBR: 1.26×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Caribou Biosciences, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).